Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, BG Trauma Center Ludwigshafen
Ludwigshafen am Rhein, Rhineland-Palatinate, 67071, Germany
NCT Number: NCT02691650
Goal of this study is to measure serum cholinesterase activity in patients with traumatic and/or burns injury admitted to the emergency room by using point-of- care-test system (POCT). Serum cholinesterase activity, measured using POCT system, might play an important role in the early diagnosis and prediction of patient outcome in trauma-induced systemic inflammation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ludwigshafen am Rhein, Rhineland-Palatinate, 67071, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: after completed patient recruitment, 1 year
By using Point-of-care measurement of serum cholinesterase activity (U/l) and by observing a change in the enzyme activity over time (reduction of serum cholinesterase activity within the first 6 hours after traumatic injury) would allow an additional tool in early diagnosis and treatment of systemic inflammation.
Time frame: after completed patient recruitment, 1 year
To evaluate the correlation of the serum cholinesterase activity change with the trauma severity, the obtained serum cholinesterase activities (U/l) will be compared to the trauma severity scores (ISS, %TBSA).
University Hospital Heidelberg
Other
Acronym: POCCET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00257231
Burns, Inflammation
Denver, Colorado, United States
View Trial DetailsNCT00257244
Burns, Inflammation
Maywood, Illinois, United States
View Trial DetailsNCT01254357
Burns, Trauma
Sacramento, California, United States
View Trial DetailsNCT01214980
Burns, Cardiovascular Diseases
Tampa, Florida, United States
View Trial Details